Table 3 Peripheral tissue immunolabelling following primary passage of sheep with L-BSE
From: L-BSE experimentally transmitted to sheep presents as a unique disease phenotype
Animal ID | Genotype | Clinical status | Survival time (days) | Ganglia | Lymphoid tissues | Muscle | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trige-minal | Nodose | Cranial cervical | Stellate | Coeliaco-mesenteric | ENS | LRLN | MLN | RAMALT | Spleen | PP | Extra-ocular | ||||
457/11 | AFRQ/AFRQ | + | 1236 | + | + | – | – | – | – | – | – | – | – | – | +a |
112/12 | + | 1334 | + | + | – | – | – | – | – | – | – | – | – | + | |
26/12 | + | 1267 | + | + | – | – | – | – | – | – | – | – | – | + | |
98/11 | + | 1186 | + | + | – | nr | – | – | – | – | – | – | – | +a | |
1606/10 | + | 867 | – | – | – | – | – | – | – | – | – | – | – | – | |
3/11 | ARQ/ARQ | + | 959 | nr | + | – | – | – | – | – | – | – | – | – | + |
182/12 | + | 1531 | + | + | – | – | – | – | – | – | – | – | – | +a | |
63/11 | + | 956 | nr | + | – | nr | – | – | – | – | – | – | – | + | |
455/11 | + | 1186 | + | + | – | – | – | – | – | – | – | – | – | +a | |
3/13 | + | 1649 | + | + | – | – | – | – | – | – | – | – | – | +a | |
223/13 | ARR/ARR | – | 1998b | – | – | – | – | – | – | – | – | – | – | – | – |
224/13 | – | 1999b | nr | nr | – | – | – | – | – | – | – | – | – | – | |
10/14 | – | 2005b | – | – | – | – | – | – | – | – | – | – | – | – | |
8/14 | – | 2000b | – | – | – | – | – | – | – | – | – | – | – | – | |
9/14 | – | 2005b | – | – | – | – | – | – | – | – | – | – | – | – | |
4/12 | ARQ/VRQ | + | 1389 | + | – | – | – | – | – | – | – | – | – | – | +a |
140/11 | + | 957 | + | + | + | – | – | – | – | – | – | – | – | + | |
1591/10 | + | 803 | + | + | – | – | – | – | – | – | nr | – | – | + | |
267/11 | + | 1056 | nr | + | inc | inc | – | – | – | – | – | – | – | + | |
58/11 | + | 864 | + | + | – | nr | – | – | – | – | – | – | – | +a | |
225/13 | VRQ/VRQ | – | 1964b | – | nr | – | – | – | – | – | – | – | – | – | – |
113/12 | + | 1337 | + | + | – | – | – | – | – | – | – | – | – | +a | |
456/11 | + | 1183 | + | nr | + | – | – | – | – | – | – | – | – | + | |
48/13 | – | 1963b | nr | nr | – | inc | + | + | + | + | + | + | + | + | |
167/12 | + | 1439 | + | + | – | – | – | – | – | – | – | – | – | + | |